Literature DB >> 7353734

Interest of a combined antisecretory treatment, cimetidine and pirenzepin, in the management of severe forms of Zollinger-Ellison syndrome.

M Mignon, T Vallot, J P Galmiche, J L Dupas, S Bonfils.   

Abstract

Inhibition of gastric acid secretion by the combined use of cimetidine and pirenzepin has been studied in 5 cases of Zollinger-Ellison syndrome. In 4 acute cases i.v. cimetidine and i.m. pirenzepin were administered together as a treatment and were successful in 3 out of the 4 cases as judged by the disappearance of clinical symptoms and healing of the gastroduodenal and jejunal mucosal ulcerations. Secretory measurements indicated that addition of pirenzepin to cimetidine resulted in larger and more prolonged inhibition of acid secretion in these patients. The continuous record of intragastric pH in the 5th patient, over 24-hour periods, confirmed the above findings. Despite the use of large doses of pirenzepin, no significant side effects were noticed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7353734     DOI: 10.1159/000198414

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  8 in total

1.  Effect of cimetidine and pirenzepine in combination on 24 hour intragastric acidity in subjects with previous duodenal ulceration.

Authors:  J G Williams; M Deakin; J K Ramage
Journal:  Gut       Date:  1986-04       Impact factor: 23.059

Review 2.  Newer antisecretory agents for peptic ulcer.

Authors:  K W Somerville; M J Langman
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

3.  Testing antisecretory drugs in Zollinger-Ellison syndrome: problems and limits in pharmacological studies.

Authors:  S Bonfils
Journal:  Dig Dis Sci       Date:  1982-04       Impact factor: 3.199

4.  New drugs for peptic ulcer.

Authors: 
Journal:  Br Med J       Date:  1980-07-12

5.  Failure of cimetidine in Zollinger-Ellison syndrome.

Authors:  J A Ziemniak; M Madura; A J Adamonis; E J Olinger; M Dreyer; J J Schentag
Journal:  Dig Dis Sci       Date:  1983-11       Impact factor: 3.199

6.  Evaluation of antisecretory drug therapy of Zollinger-Ellison syndrome (ZES) using 24-hour pH monitoring.

Authors:  T Vallot; M Mignon; R Mazure; S Bonfils
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199

7.  Effect of isopropamide on response to oral cimetidine in patients with Zollinger--Ellison syndrome.

Authors:  D M McCarthy; P E Hyman
Journal:  Dig Dis Sci       Date:  1982-04       Impact factor: 3.199

Review 8.  Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases.

Authors:  A A Carmine; R N Brogden
Journal:  Drugs       Date:  1985-08       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.